X

CRL

Charles River Laboratories International, Inc (CRL) Sec Form 8K

Charles River Laboratories International, Inc (NYSE: CRL) Sec Form 8K

Charles River Laboratories International, Inc (CRL) Charles River Laboratories Provides Update on Planned Divestitures

Charles River Laboratories International, Inc (NYSE: CRL) FY 2026 Other Release

Charles River Laboratories International, Inc (CRL) Q4 2025 Earnings Call Transcript

Charles River Laboratories International, Inc (NYSE: CRL) Q4 2025 Earnings Call dated Feb. 18, 2026 Corporate Participants: Todd Spencer —…

Charles River Laboratories International, Inc (CRL) Sec Form 10K

Charles River Laboratories International, Inc (NYSE: CRL) Sec Form 10K

Charles River Laboratories International, Inc (CRL) Sec Form 8K

Charles River Laboratories International, Inc (NYSE: CRL) Sec Form 8K

Charles River Laboratories (CRL) Q4 revenue, adjusted earnings top expectations

Charles River Laboratories International, Inc. (NYSE: CRL), a provider of products and services for pharma companies to accelerate drug discovery…

Charles River Laboratories International, Inc (CRL) Charles River Laboratories Announces Executive Appointments

Charles River Laboratories International, Inc (NYSE: CRL) FY 2026 Management Update

Charles River Laboratories International, Inc (CRL) Q4 2025 Earnings Call

Charles River Laboratories International, Inc (NYSE: CRL) Q4 2025 Earnings Conference

Charles River Laboratories International, Inc (CRL) Q4 2025 Earnings Results

Charles River Laboratories International, Inc (NYSE: CRL) Q4 2025 Earnings Release

Charles River Laboratories International, Inc (CRL) Provides 2026 Guidance

Charles River Laboratories International, Inc (NYSE: CRL) FY 2026 Other Release